温星桥，毕业于1998年6月，对泌尿系统疾病如泌尿系肿瘤、肾结石、前列腺疾病等的临床诊断与药物、手术、微创治疗有熟练经验。主持两项国家自然科学基金课题( 30600620 ， 30872585 )。参与获 广东省科学技术奖《腹腔镜泌尿外科切除与成形手术的临床研究及应用推广》。获中山三院“优质服务医师奖”、“优秀共产党员”、“优秀教师”称号。广东省高校“千百十人才工程”培养对象。

人物论著

1. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 2005, 65 : 9807–16.

2. Knock-down of p21-activated kinase 6(PAK6) inhibits prostate cancer growth and enhances chemosensitivity docetaxel. Urology, 2008, accepted.

3. One-Step Percutaneous Nephrostomy in Patients with a History of Open Nephrolithotomy: Comparison with the Fascial Dilator System . J of Endourology , 2007,21(11):1281-5

4. Reduced expression of tocopherol-associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence . Asian J Andrology ,2007 , 9 (2):206-12

5. Endourologic Treatments of Distal Ureteral Obstruction in Patients with History of Pelvic Malignancies:Efficacy and Safety Evaluation. Ai Zheng . 2007; 26 : 1227-30 .

6. 改良“一步式”经皮肾造瘘法的临床应用评价. 中华泌尿外科杂志， 2007,28(8):515-517

7. 维生素 E 对前列腺癌微小染色体维持蛋白 4 的抑制作用及信号通路. 中华实验外科杂志 ,2007,24(8):960-962

8.不同类型 P21 活化激酶 -6 活性对前列腺癌增殖的影响 . 中华泌尿外科杂志 ,2006,27(8):552-555